Gastric cancer often develops through a gradual sequence of changes, beginning with superficial gastritis and advancing through chronic atrophic gastritis, intestinal metaplasia, and precancerous ...

ABSTRACT: Gastric cancer is one of the most common malignant tumors in the world. Gastric cancer continues to represent a major global health concern, with its high mortality rates and widespread ...

Gastric cancer, one of the leading causes of cancer-related mortality globally, faces challenges in treatment due to limitations in surgery, chemotherapy resistance, and high recurrence rates.

Researchers are estimating 15.6 million lifetime gastric cancer cases globally, with more than three-quarters attributable to Helicobacter pylori, among young people, according to a study published in ...

Share on Pinterest About three-quarters of gastric cancer cases worldwide have been linked to the common bacteria H. pylori. Courtney Hale/Getty Images The vast majority of stomach cancer cases have ...

Adcentrx Therapeutics advances gastric cancer treatment with FDA orphan drug designation for ADRX-0405, a promising antibody-drug conjugate in clinical trials. The FDA has granted orphan drug ...

Globally, stomach cancer is on the rise in young people, but new research shows that three-quarters of future cases could be prevented by screening for and treating a common bacterial infection: ...

June 30 (Reuters) - Amgen (AMGN.O), opens new tab said on Monday its experimental therapy helped patients with advanced gastric cancer live longer when combined with chemotherapy, according to interim ...

1 Department of Surgery and Anesthesiology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nangjing, China 2 Department of Anesthesiology, Huainan First People’s Hospital, The First ...

New findings reveal bemarituzumab plus chemotherapy significantly improves survival in advanced gastric cancer, offering hope for targeted treatment options. First-line treatment with bemarituzumab ...